| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |